$AIFF

Firefly Neuroscience (AIFF) updated its brain-computer interface strategy, highlighting its Versus platform. The company has shipped 3,000 Versus headsets, which use wireless EEG technology for brainwave activity tracking in simulations. Firefly aims to leverage this data for AI applications and brain health. The Versus platform generates commercial revenue while the company pursues BCI and AI development. AIFF's Evoke System is FDA-cleared for diagnostic and treatment monitoring.

Firefly Neuroscience (AIFF) and NeuroSigma partnered to promote NeuroSigma's Monarch eTNS System, a non-drug ADHD treatment, through Firefly's Evoke platform network. AIFF shares rose 38.9% to $1.65. According to a 2024 study, 7.1 million U.S. children have ADHD, with many seeking non-medication treatments.

Aethlon Medical (AEMD) surged 360% after announcing a merger with North Immunology and a $180M private placement. Tiziana Life Sciences (TLSA) rose 22% due to a clinical trial collaboration. Capricor Therapeutics (CAPR) gained 9% with upcoming Duchenne data. Firefly Neuroscience (AIFF) climbed 26% after a brain-medicine partnership. Clearmind Medicine (CMND) increased 6% following an FDA psychedelic hearing.

Firefly Neuroscience (AIFF) partners with Radial to integrate its Evoke EEG platform with RadialOS, aiming to enhance brain-function diagnostics and treatment personalization. Evoke uses AI to analyze brain activity, aiding in conditions like depression and ADHD. Radial operates 27 clinics, treating thousands annually. AIFF stock is up 11.83% at $1.04.

FIREFLY NEUROSCIENCE, INC. (AIFF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, the board of directors (the “Board”) of Firefly Neuroscience, Inc., a Delaware corporation (the “Comp

FIREFLY NEUROSCIENCE, INC. (AIFF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 5, 2026, at the 2026 annual meeting of stockholders (the “ Annual Meeting ”) of Firefly Neuroscience, Inc., a Del

Firefly Neuroscience (NASDAQ: AIFF) said TMS center customer clinical assessments using its FDA 510(k)-cleared AI-powered EEG/ERP platform Evoke rose about 291% year over year, nearly four-fold. The company said Evoke combines qEEG and ERP to support clinician assessment of conditions including depression, anxiety, and ADHD, including monitoring before, during, and after TMS.

FIREFLY NEUROSCIENCE, INC. (AIFF) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. false 0000803578 0000803578 2026-06-25 2026-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Repor

FIREFLY NEUROSCIENCE, INC. (AIFF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ea029547601ex10-1.htm EMPLOYMENT AGREEMENT BETWEEN DEEL INNOVATION LTD. AND GIL ISSACHAR, DATED JUNE 18, 2026 Exhibit 10.1 Employment Agreement This Employment Agreement, is entered into on June 18th, 2026 by and between DEEL INNOVATION LTD. , an Israeli company registe

KENMORE, N.Y. and MIAMI, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Firefly Neuroscience, Inc. ( "Firefly" ) ( NASDAQ: AIFF ) , an Artificial Intelligence ( "AI" ) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today ...